Breakdown | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 299.36M | 227.58M | 179.63M | 82.06M | 90.42M |
Gross Profit | 260.89M | 199.60M | 154.77M | 69.20M | 79.86M |
EBITDA | 93.66M | 67.63M | 40.39M | 5.86M | -4.14M |
Net Income | 40.75M | 16.37M | -8.78M | -26.96M | -31.86M |
Balance Sheet | |||||
Total Assets | 194.48M | 208.14M | 219.66M | 246.94M | 199.18M |
Cash, Cash Equivalents and Short-Term Investments | 19.31M | 19.22M | 1.64M | 39.38M | 39.22M |
Total Debt | 45.55M | 66.38M | 94.44M | 111.97M | 56.72M |
Total Liabilities | 134.23M | 188.64M | 216.53M | 235.03M | 160.31M |
Stockholders Equity | 60.25M | 19.50M | 3.13M | 11.91M | 38.87M |
Cash Flow | |||||
Free Cash Flow | 18.28M | 41.87M | -9.71M | 6.82M | -8.39M |
Operating Cash Flow | 31.74M | 74.07M | 24.73M | 23.91M | 15.69M |
Investing Cash Flow | -6.91M | -32.18M | -34.45M | -9.54M | -23.61M |
Financing Cash Flow | -24.71M | -24.31M | -28.02M | -14.21M | -17.23M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
74 Outperform | HK$1.02B | 22.38 | 54.98% | ― | 42.14% | 251.52% | |
62 Neutral | HK$220.69M | 4.21 | 17.83% | ― | 6.62% | 72.58% | |
57 Neutral | HK$25.55B | 4.08 | -2.03% | 5.79% | -0.31% | -67.64% | |
52 Neutral | HK$60.29M | ― | -34.02% | ― | -6.40% | -333.90% | |
49 Neutral | HK$21.00M | ― | -6.50% | ― | ― | ― | |
45 Neutral | HK$183.17M | ― | ― | -56.57% | -49.64% | ||
32 Underperform | HK$48.00M | ― | -39.40% | ― | -36.11% | 55.34% |